# Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Study · id `cardio:ct-nct01212900` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01212900](<https://clinicaltrials.gov/study/NCT01212900>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01212900

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

## Technical summary

Registry record NCT01212900. Randomized; single masking; primary purpose treatment. Start 2010-09-30 (registry gives no type); primary completion 2016-11-30 (actual). Results posted on 2018-10-31.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 230 participants (enrolled count; ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Start date: 2010-09-30 (registry gives no type) (ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Primary completion: 2016-11-30 (actual) (ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Completion: 2017-02-22 (actual) (ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Results first posted: 2018-10-31 (ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01212900, source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01212900-2018-11-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
- Condition: Atherosclerosis
- Condition: Hypercholesterolemia
- Intervention (Drug): Statins, HMG CoA
- Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Lead sponsor class: NIH

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as the lead sponsor: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 88c1011f363359b17ffc5ec27406c3784102af53a3936f40fedc8b9c091634b1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
